The relationship between myocardial perfusion scanning results, C-reactive protein to albumin ratio, systemic inflammatory response index and coronary angiographic findings

Yasin Yüksel 1, Cennet Yıldız 2 *
More Detail
1 Department of Cardiology, Istanbul Education and Research Hospital, Istanbul, Turkey
2 Department of Cardiology, Bakırköy Dr Sadi Konuk Education and Research Hospital, Istanbul, Turkey
* Corresponding Author
J CLIN MED KAZ, Volume 19, Issue 4, pp. 48-52. https://doi.org/10.23950/jcmk/12332
OPEN ACCESS
Download Full Text (PDF)

ABSTRACT

Aim: We aimed to investigate whether C-reactive protein to albumin ratio (CAR) and systemic inflammatory response index (SIRI) have an additional value in interpretation of myocardial perfusion scanning (MPS) results.
Background: MPS have high sensitivity but relatively low specificity in diagnosis of coronary artery disease (CAD).
Material and methods: 449 patients who had MPS before coronary angiography were included.  Patients with and without CAD constituted study (n=227) and control (n=222) groups, respectively.
Results: Sensitivity and specificity of MPS in detecting CAD were found to be as 97.8% and 62.2%, respectively.  CAR value of 1.22 and SIRI value of 1.45 predicted CAD with a sensitivity of 61.2% and 59% and specificity of 77% and 80.2%, respectively. Only 10.4 % of the CAD negative patients had positive MPS and positive CAR values, whereas 0.9% of the CAD positive patients had negative MPS and negative CAR values.  27.5% of CAD negative patients had positive MPS and negative CAR values. Likewise, having a negative MPS with negative SIRI value identified 50% of the patients who had normal coronary arteries. Positive MPS with positive SIRI value correctly identified 58.1% of patients who had CAD.
Conclusion: evaluation of CAR and SIRI might be beneficial in interpretation of MPS.

CITATION

Yüksel Y, Yıldız C. The relationship between myocardial perfusion scanning results, C-reactive protein to albumin ratio, systemic inflammatory response index and coronary angiographic findings. J CLIN MED KAZ. 2022;19(4):48-52. https://doi.org/10.23950/jcmk/12332

REFERENCES

  • Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: A Report From the American Heart Association. Circulation. 2017; 135(10):e146-e603. https://doi.org/10.1161/CIR.0000000000000485
  • Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol. 1990; 15(2):318-29. https://doi.org/10.1016/s0735-1097(10)80055-5
  • Li DL, Kronenberg MW. Myocardial Perfusion and Viability Imaging in Coronary Artery Disease: Clinical Value in Diagnosis, Prognosis, and Therapeutic Guidance. Am J Med. 2021; 134(8):968-75. Epub 2021 Apr 20. https://doi.org/10.1016/j.amjmed.2021.03.011
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9):1135–43. https://doi.org/10.1161/hc0902.104353
  • Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, et al. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol. 1998; 30(12):2567–76. https://doi.org/10.1006/jmcc.1998.0829
  • Kalyoncuoğlu M, Gunduz D. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020; 31(2):130-136. https://doi.org/10.1097/MCA.0000000000000768
  • Liu Y, Ye T, Chen L, Jin T, Sheng Y, Wu G, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715-720. https://doi.org/10.1097/MCA.0000000000001037
  • Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002; 18(1):539-42. https://doi.org/10.1161/hc0402.102975
  • Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005; 1(2):219-27.
  • Verna E, Ceriani L, Giovanella L, Binaghi G, Garancini S. "False-positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies. J Nucl Med. 2000; 41(12):1935-40.
  • McGee M, Ferreira D, Tvedten O, Mahmoodi E, Whitehead N, Baker D, et al. Specificity of Myocardial Perfusion Imaging: Issues With Proposed MBS Item Review. Heart Lung Circ. 2019; 28(3):e23-e25. Epub 2018 May 27. https://doi.org/10.1016/j.hlc.2018.04.304
  • Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(9):2045–2051. https://doi.org/10.1161/ATVBAHA.108.179705
  • Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2007; 99(8):1055–61. Epub 2007 Mar 6. https://doi.org/10.1016/j.amjcard.2006.11.066
  • Gaul DS, Stein S, Matter CM. Neutrophils in cardiovascular disease. Eur Heart J. 2017; 38 (22):1702–04. https://doi.org/10.1093/eurheartj/ehx244
  • Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000; 102(18):2165-2168. https://doi.org/10.1161/01.cir.102.18.2165
  • Bisoendial RJ, Boekholdt SM, Vergeer M, Stores ES, Kastelein JJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010; 31(17):2087-91. Epub 2010 Aug 3. https://doi.org/10.1093/eurheartj/ehq238
  • Jialal I,Devaraj S, Venugopal SK. C-reactive protein:risk marker or mediator in atherothrombosis? Hypertension. 2004; 44 (1):6-11. Epub 2004 May 17. https://doi.org/10.1161/01.HYP.0000130484.20501.df
  • Mukai H, Villafuerte H, Qureshi AR, Lindholm B, Stenvinkel P. Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment. Seminars in Dialysis. 2018; 31(5):435-9. https://doi.org/10.1111/sdi.12731
  • Oduncu V, Erkol A, Karabay CY, Kurt M, Akgun T et al. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coronary Artery Disease. 2013; 24(2):88-94. https://doi.org/10.1097/MCA.0b013e32835c46fd
  • Kurtul A, Murat SN, Yarlioglues M, Duran M, Ocek AH et al. Usefulness of Serum Albumin Concentration to Predict High Coronary SYNTAX Score and In-Hospital Mortality in Patients With Acute Coronary Syndrome. Angiology. 2016; 67(1):34-40. https://doi.org/10.1177/0003319715575220
  • Karabag Y, Cagdas M, Rencuzogulları I, Karakoyun S, Artac I, Ilıs D, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32(7):e22457. Epub 2018 Apr 18. https://doi.org/10.1002/jcla.22457
  • Jin Z, Wu Q, Chen S, Gao J, Li X, Zhang X, et al. The Associations of Two Novel Inflammation Indexes, SII and SIRI with the Risks for Cardiovascular Diseases and All-Cause Mortality: A Ten-Year Follow-Up Study in 85,154 Individuals. J Inflamm Res. 2021; 14:131-140. eCollection 2021. https://doi.org/10.2147/JIR.S283835